Cancidas caspofungin acetate regulatory update

EMEA's CHMP recommended extending the indication for Merck's Cancidas caspofungin to include pediatric patients age 12 months to 17 years old. The inhibitor of beta 1,3-D-glucan in fungal cell walls i...